Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$59,991,980
in 20 filings, $60.0M under 10b5-1 plans

Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 82 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-09-18 Anders Jack Chief Financial Officer Sale −1,427 $31.31 $45K 53,667
2023-09-18 Horn Margaret A Chief Operating Officer Sale 10b5-1 −2,514 $31.31 $79K 96,960
2023-09-15 Horn Margaret A Chief Operating Officer Exercise or conversion 10b5-1 +5,000 $4.09 $20K 104,474
2023-09-15 Horn Margaret A Chief Operating Officer Sale 10b5-1 −5,000 $32.08 $160K 99,474
2023-09-15 Horn Margaret A Chief Operating Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −5,000 103,302
2023-09-01 GOLDSMITH MARK A Director Exercise or conversion +17,993 $0.54 $10K 375,379
2023-09-01 GOLDSMITH MARK A Director Exercise or conversion +12,007 $1.12 $13K 387,386
2023-09-01 GOLDSMITH MARK A Director Sale −30,000 $35.05 $1.1M 357,386
2023-09-01 GOLDSMITH MARK A Director Sale −5,000 $35.04 $175K 35,424
2023-09-01 GOLDSMITH MARK A Director Sale −5,000 $35.04 $175K 35,424
2023-09-01 GOLDSMITH MARK A Director Exercise or conversion · Stock Option (Right to Buy) −17,993 205,503
2023-09-01 GOLDSMITH MARK A Director Exercise or conversion · Stock Option (Right to Buy) −12,007 46,479
2023-09-01 Weber Barbara Director Exercise or conversion +3,854 $1.12 $4K 19,679
2023-09-01 Weber Barbara Director Exercise or conversion +11,146 $4.73 $53K 30,825
2023-09-01 Weber Barbara Director Sale −15,000 $35.07 $526K 15,825
2023-09-01 Weber Barbara Director Exercise or conversion · Stock Option (Right to Buy) −3,854 9,635
2023-09-01 Weber Barbara Director Exercise or conversion · Stock Option (Right to Buy) −11,146 1,851
2023-09-01 Anders Jack Chief Financial Officer Exercise or conversion 10b5-1 +20,000 $2.68 $54K 75,094
2023-09-01 Anders Jack Chief Financial Officer Sale 10b5-1 −20,000 $35.05 $701K 55,094
2023-09-01 Anders Jack Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −20,000 42,201

Page 31 of 39 · 775 trades